Jump to content
RemedySpot.com

Lymphomation: What's New Digest - Aug 6, 2011

Rate this topic


Guest guest

Recommended Posts

Guest guest

What's New Digest - Aug 6, 2011

Greetings all,

Just back from an intensive six-day workshop on Clinical Trial Methods

sponsored by AACR and ASCO.

Here's our lymphomation list of items for the week, grouped by topic - a few

days late.

As always, view at your leisure - the links are posted to News and Reports:

www.lymphomation.org/current.htm

OR www.facebook.com/lymphomation.PAL (requires facebook account)

==

Survivorship

Who's a Survivor? An oncologist who's had breast cancer considers the

problematic phrase " cancer survivor. " What do you think about the use of

" survivor? "

End of life issues: The Truth About Hospice Care

You Look Great’ and Other Lies

The Doctor Will See You ... Eventually

With cancer, sometimes there is no right answer

Men, Cancer & Work: Coming to Terms with the " New Normal "

Patients want and need to take a greater role in their medical care

Free subscription to Cure magazine

Hospice medical care for dying patients

Very difficult to read, but excellent article on end of life care and

hospice--warning- not for the faint hearted-- but does raise issues to think

about

Surveillance CT scans are a source of anxiety and fear of recurrence in

long-

term lymphoma survivors

Encouragement PAL

===

Reports / Background

Bortezomib (Velcade) plus rituximab versus rituximab alone in follicular

lymphoma: a randomized trial

Bortezomib Combo Effective in Advanced Follicular Lymphoma

Is Benefit of Bortezomib in Follicular Lymphoma Worthwhile?

Improving radiation Rx safety

Zevalin, Fludarabine, and TBI-based " mini " allogeneic transplantation

Treatment-Induced Oxidative Stress and Cellular Antioxidant Capacity

Determine Response to Bortezomib in MCL

Prognostic Index Predicts Survival for Patients With MCL Autologous

Stem-Cell Transplantation

Chemotherapy Primer: Why? What? and How?

Who was Hodgkin?

Answers to questions about sunscreen from Memorial Sloan-Kettering

dermatologist Wang

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's

lymphoma:

Life After Cancer | National Comprehensive Cancer Network

Choice of Pre-Transplant Chemotherapy Regimen May Not Be As Important As

Other Factors in Mantle Cell Lymphoma

Novel Treatment Regimens for Waldenström's Macroglobulinemia

Clinical guidelines for treatment of follicular lymphoma

The Non-Hodgkin's Lymphomas

===

Videos / Webcasts / Cartoons

Video on natural " cures "

NIH interview with Siddhartha Mukherjee, M.D., Ph.D., 2011 Pulitzer Prize

winner for his book " The Emperor of All Maladies: A Biography of Cancer. " A

fairly long but interesting video

About DCA

Help dealing with stress as a cancer caregiver video

Cancer cartoons

===

Advocacy and Notices

Petition for Bexxar and Zevalin!

Drug Shortages and How to Address!

My Experience at AACR/ASCO Clinical Trial Methods Workshop

Upcoming LRF teleconferences--

ASCO, ASH, 3 part series on T cell

===

Clinical Trials

TLR8 Agonist VTX-2337 in Combo With Local Radiation in Low-Grade B-cell

Lymphomas

Lenalidomide + Rituximab as Front-Line Therapy for Untreated MCL

Waldenström's studies http://1.usa.gov/qXxeLv

Trials of interest based on clinical circumstances

===

PAL Updates

Tips for Minimizing Anxiety and Pain during blood draws and IV preparations

PET scan - clinical use of: " very little is certain and agreed upon. "

Optimizing Doctor Visits page

Oral Mucositis page - Inflammation of the mucosa (such as oral cavity) PAL

Fatigue page - whether treatment- or lymphoma-related it can be treated. PAL

===

Food for Thought

Advances in cancer treatment are hyped by headlines

Use of Chemo Assays Outside Clinical Trials Still a No No

R.I.P. Servan-Schreiber (very critical review of his book Anti-cancer:

A new way of life)

Ruling Upholds Gene Patent in Cancer Test

New Dietary Ingredient (NDI) rules planned for the supplement industry

Alternative Therapies for Curing Cancer: What Do Patients Want? What Do

Patients Need?

Difference between hematological malignancy and Solid tumor research

articles

published in four major medical journals

Risk for second malignancies in NHL survivors: a meta-analysis

Annual Review 2010/11 – Revolutionizing the way we diagnose and treat cancer

Growing Up Near Livestock Tied to Blood Cancers

===

Technical

Disappearance of Genetic Material Allows Tumor Cells to Grow

Cancer statistics 2011

DNA switches tied to non-Hodgkin lymphoma Genetic defects lead to altered

activity in other genes

Annual Review – Understanding why cancer spreads and why it can come

back

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma (Full

article in Nature)

Technical but interesting article Controversies in clinical cancer dormancy

Links posted to News and Reports: www.lymphomation.org/current.htm

OR www.facebook.com/lymphomation.PAL (requires facebook account)

~ Karl

PATIENTS (helping-to-make-progress) AGAINST LYMPHOMA

www.lymphomation.org

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...